JESSICA FISHER: Open Payments
NPI 1710540950 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 17 payments from 14 companies in 2025. Trend: 2023 $164 · 2024 $419 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 1 | $57 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Genentech USA, Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Karyopharm Therapeutics Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| ARRAY BIOPHARMA INC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $23 |
Products named: RYTELO, KEYTRUDA, XPOVIO, Vanflyta, Itovebi, AYVAKIT, LORBRENA, KISQALI.
Industry payments across MI — which companies pay providers there.
